Mein Warenkorb

VSIG4

VSIG4 Molekülinformation

Englischer NameV-set and immunoglobulin domain-containing protein 4Anzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel1Target-AliasProtein Z39Ig,CRIg,Z39IG
Höchste Forschungs- und EntwicklungsphasePhase 1 Clinical
Englischer NameV-set and immunoglobulin domain-containing protein 4
Target-AliasProtein Z39Ig,CRIg,Z39IG
Anzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel1
Höchste Forschungs- und EntwicklungsphasePhase 1 Clinical

VSIG4 Produktliste

  • Attribut

    Protein (2)

  • Produktbibliothek

    Online (2)

  • Spezies

    Human (2)

  • Etikett

    His Tag (1)His Tag & Avi Tag (1)

  • Marker

    Unconjugated (1)Biotin-labeled (1)

ProduktnummerSpeziesExpressionssystemProduktbeschreibungProteinstrukturReinheitEigenschaftenVorbestellen/Bestellen
Human
HEK293
Human VSIG4 Protein, His Tag
In den Warenkorb legen
Human
HEK293
Biotinylated Human VSIG4 Protein, His,Avitag™ (MALS verified)
In den Warenkorb legen
Gesamtmenge2
  • 1

VSIG4 Molekülhintergrund

V-set and immunoglobulin domain-containing protein 4 (VSIG4) is also known as Protein Z39Ig, is a type I transmembrane glycoprotein. VSIG4 is a B7 family-related protein and an Ig superfamily member. VSIG4 contains two Ig-like (immunoglobulin-like) domains. VSIG4 is abundantly expressed in several fetal tissues. In adult tissues, the highest expression of VSIG4 is in lung and placenta. VSIG4 functions as a negative regulator of T cell activation, and may be involved in the maintenance of peripheral T cell tolerance, and is also identified as a potent suppressor of established inflammation. VSIG4 is a phagocytic receptor, strong negative regulator of T-cell proliferation and IL2 production.

VSIG4 Molekülalias

VSIG4,CRIg,Z39IG

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
EU-103EU-103Phase 1 ClinicalEutilexNeoplasms; Solid tumours
Details
  • Produktliste
  • Klinische Arzneimittelinformation
Kontaktieren Sie uns